Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression.
暂无分享,去创建一个
V. Laudone | David A. Amato | R. Badalament | W. Fair | W. Whitmore | H. Herr | D. Amato | W R Fair | H W Herr | R A Badalament | D A Amato | V P Laudone | W F Whitmore | H. Herr | H. Herr
[1] D. Cox. Regression Models and Life-Tables , 1972 .
[2] J. Kalbfleisch,et al. The Statistical Analysis of Failure Time Data , 1980 .
[3] J R Anderson,et al. Analysis of survival by tumor response. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] R. Badalament,et al. A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancer. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] N. Geller,et al. Intravesical administration of bacillus Calmette-Guérin in patients with recurrent superficial carcinoma of the urinary bladder: report of a prospective, randomized trial. , 1985, Cancer treatment reports.
[6] A. Althausen,et al. Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. , 1976, The Journal of urology.
[7] E. Silverberg,et al. Cancer statistics, 1987 , 1987, CA: a cancer journal for clinicians.
[8] M. Melamed,et al. Monitoring intravesical bacillus Calmette‐Guerin treatment of superficial bladder carcinoma by serial flow cytometry , 1986, Cancer.
[9] M. Soloway. Rationale for intensive intravesical chemotherapy for superficial bladder cancer. , 1980, The Journal of urology.
[10] S. Loening,et al. Superficial bladder cancer: progression and recurrence. , 1983, The Journal of urology.
[11] F. Freiha,et al. Superficial bladder cancer: the primacy of grade in the development of invasive disease. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] N. Geller,et al. Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. , 1985, The Journal of urology.
[13] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[14] R. Barnes,et al. Survival following transurethral resection of bladder carcinoma. , 1977, Cancer research.
[15] Utz Dc,et al. Management of carcinoma in situ of the bladder: the case for surgical management. , 1980 .
[16] G. Prout. Bladder carcinoma and a TNM system of classification. , 1977, The Journal of urology.
[17] W. Catalona,et al. Risks and benefits of repeated courses of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer. , 1987, The Journal of urology.
[18] G. Farrow,et al. The plight of the patient with carcinoma in situ of the bladder. , 1970, The Journal of urology.
[19] W Lutzeyer,et al. Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. , 1982, The Journal of urology.
[20] G. Murphy,et al. Superficial bladder tumor. Aspects of clinical progression. , 1974, Urology.